Comparison VectivBio (VECT) with Competitors
VectivBio (VECT) industry is Pharmaceuticals.
Operating Margin
VECT-294.50%
Industry-294.50%
Upside-
Debt-to-Equity
VECT4.90%
Industry4.90%
Upside-
Free Cash Flow Yield
VECT1.76%
Industry1.76%
Upside-
P/E
VECT-5.50
Industry-5.50
Upside-
P/S
VECT21.08
Industry21.08
Upside-
P/B
VECT3.62
Industry3.62
Upside-